ACVC Research Prize 2018 edition
Four finalists selected from the highest scoring abstracts presented their unpublished work in this dedicated session. The winner of the ACVC Research Prize in Acute Cardiovascular Care was announced at the end of the session and the prize (3000 Euros) and diploma was handed over by ACVC president Dr Maddalena Lettino.
The ACVC Research Prize in Acute Cardiovascular Care is a highly competitive and prestigious annual prize for unpublished research. The young and fast growing Acute Cardiovascular Care Association is the primary scientific community for research in the field of acute cardiovascular care. With the successful establishment of the annual research prize, ACVC confirms its role as the leading scientific association in acute cardiovascular care leveraging clinical and translational research in the field.
The ACVC research prize was released for the first time in Geneva 2014.
Discover the Winner
Martin Frydland (Copenhagen, Denmark)
I graduated from Aarhus University, Denmark in 2012.
My interest in acute cardiology began during medical school where I worked with a pre-conditioning/myocardial infarction porcine model. After graduation, I focused on training in cardiology, working in the clinic for 3 years with acute cardiovascular diseases. During my clinical work, my interest in acute cardiology increased and I have written papers on cardiac arrest and cardiogenic shock. This spring, I will turn in my phd-thesis on biomarkers in cardiogenic shock at Copenhagen University with professor Christian Hassager as my primary supervisor.
Hereafter, I will continue my specialist training in cardiology.
‘’Biomarkers reflecting cardiovascular stress, neuroendocrine response, and inflammation are predictive of late cardiogenic shock in patients with suspected ST-elevation myocardial infarction’’
In this study, we assessed the predictive value of biomarker plasma level on late cardiogenic shock development in >2.000 consecutive patients admitted for acute coronary angiography with suspected STEMI.
And the 3 finalists
Marek Gierlotka (Zabrze, Poland)
He studied medicine at the Medical University of Silesia. Affiliated to the 3rd Department of Cardiology in Silesian Centre for Heart Diseases in Zabrze as a Deputy Head for Intensive Cardiac Care and Acute Coronary Syndromes. Interventional cardiologist. Associate Professor. He specializes in the methodology and analysis of big registry data, both from epidemiological and clinical perspective. Since 2003, co-author and coordinator of the Polish Registry of Acute Coronary Syndromes PL-ACS, and since 2013 Co-Chair of the Scientific Board of the Nationwide Database of Acute Myocardial Infarction AMI-PL. Current President of Intensive Cardiac Care and Resuscitation Section of Polish Cardiac Society.
“12-month mortality after early and late resuscitated cardiac arrest in acute myocardial infarction”
Early resuscitated cardiac arrest is associated with lower mortality than late. However, adjusted effect of early and late resuscitated cardiac arrest on 12-month post-discharge mortality seems to be comparable.
Aleksandra Gombozhapova (Tomsk, Russia)
Aleksandra Gombozhapova studied Medicine at Siberian State Medical University (Tomsk, Russia), graduating in 2012.
Her training at clinical residency in cardiology was completed in the Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC), in 2014. Currently, she is a cardiologist and research fellow at the Department of Cardiac Emergency, Cardiology Research Institute, TNRMC, and is completing her PhD thesis in cardiology.
Her research work is devoted to the role of cardiac macrophages in wound healing in patients with myocardial infarction (MI). In the course of performance of this work, a research protocol using macrophage biomarkers was suggested in order to study the cellular basis of cardiac remodeling in patients with acute MI.
‘’Cardiac macrophages in wound healing following myocardial infarction: from experiment to clinic’’
Our study translated experimental knowledge regarding macrophage subpopulations in post-infarction myocardial regeneration into clinical and supported diagnostic prospects for implementation of macrophage phenotyping in clinical practice. Identifying effective markers of different macrophage subsets in patients with MI might become the basis of a method to predict adverse cardiac remodeling and the first step in developing myocardial regeneration target therapy.
Idit Dobrecky (Haifa, Israel)
Doctor Idit Dobrecky Mery, 48 years old, married with 4 children, graduated with honor in 1992 from Technion Institute Medical School.
He completed both residencies in Internal medicine and Cardiology in Carmel hospital in Haifa, Israel (both with honors).
Fellow in CT Cardiac imaging in Carmel hospital with Dr Tamar Gaspar and Prof Roberto Lang (Northwestern Chicago University)
Current Director of ICCU Bnai Zion Haifa Israel and senior lecturer in the Technion Haifa faculty of medecine.
‘’Hypoglycemic events during hospitalization in diabetic acute coronary syndrome patients treated with vildagliptin vs. guidelines based medical therapy’’
We studied Vildagliptin for improved glucose levels control in diabetic ACS patients with the caution of preventing hypoglycemia while intensifying the glucose control.
8 cases of hypoglycemia occurred in the control group in comparison to none in the Vildagliptin treated patients (t (45) =2.070, p<.001).
Our mission: To reduce the burden of cardiovascular disease.